This is a searchable database of information about tests offered by Severn Pathology. You can browse the index, enter a test name, part of a test name, abbreviation or clinical indication below.
The containers listed refer to those used to collect samples from adults locally in GP practices and hospital wards/outpatients. Details of the containers used for neonates, children and in the emergency zone (ED, AAU, ITU) can be found here Tube Guide and Recommended Order of Draw.
After performing a search for a specific test, the Reset button can be clicked to go back to the A-Z test list.
Special notes | Tube type | Sample type | Test name | Ideal volume | Turnaround time | Discipline |
---|---|---|---|---|---|---|
24 | Serum | 1,25-Dihydroxy Vitamin D | 5 mL | 4 weeks | Clinical Biochemistry | |
24 | Serum | 11-deoxycortisol | 1 mL | 1 week | Clinical Biochemistry | |
20 | Plasma | 17 OHP | 5 mL | 14 days | Clinical Biochemistry | |
31 | Blood spot | 17 OHP | see notes | 14 days | Clinical Biochemistry | |
17 | Plasma (fluoride oxalate) | 3-Hydroxybutyrate | 5 mL | 7 days | Clinical Biochemistry | |
24 | Serum | 5-Alpha Dihydrotestosterone | 1 mL | 28 days | Clinical Biochemistry | |
2 | Urine - 24 hour | 5-HIAA | n/a | 7 days | Clinical Biochemistry | |
20 | Plasma | 7-dehydrocholesterol | 2 mL | 28 days | Clinical Biochemistry | |
14 | Whole blood | ABO Antibody Titration for ABO Incompatible Renal Transplantation | 8 ml | 7 working days | Immunology | |
34 | CSF | ACE | 500 uL | 6 weeks | Clinical Biochemistry | |
24 | Serum | ACE | 5 mL | 7 days | Clinical Biochemistry | |
24 | Serum | Acetylcholine Receptor Antibody | 2 mL | 3 weeks | Immunology | |
24 | Serum | Aciclovir/CMMG | <3 days | Antimicrobial Reference Laboratory | ||
14 | Plasma | ACTH | 5 mL | 5 days | Clinical Biochemistry | |
9 | Blood spot | Acylcarnitines | 1x Spot | 21 days | Clinical Biochemistry | |
20 | Plasma | Acylcarnitines | 2 mL | 21 days | Clinical Biochemistry | |
13 | Plasma | ADAMTS13 | 48 hours | Haematology | ||
34 | Fluid | Adenosine Deaminase in TB | 1 mL | 14 days | Clinical Biochemistry | |
34 | Bronchoalveolar lavage (BALs) and Sputums | Adenovirus Molecular assay (NAAT) |
500µL | 2 days | Virology | |
43 | Swabs (nose and throat) | Adenovirus Molecular assay (NAAT) |
500µL | 2 days | Virology | |
34 | Nasopharayngeal aspirates (NPAs) | Adenovirus Molecular assay (NAAT) |
500µL | 2 days | Virology | |
11 | Faecal sample | Adenovirus PCR (In house) |
pea sized amount | 2 days | Virology | |
43 | Swab (eye) | Adenovirus (qualitative) PCR (In house) |
500µl | 3 days | Virology | |
14 | EDTA Blood sample | Adenovirus (quantitative) PCR (In house) |
450µl | 3 days | Virology | |
24 | Serum | Adrenal Cortex Antibody | 2 mL | 14 working days | Immunology | |
24 | Serum | AFP | 5 mL | 1 day | Clinical Biochemistry | |
34 | CSF | AFP | 2 mL | 21 days | Clinical Biochemistry | |
24 | Serum | Albumin | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
24 | Fluid | Albumin | 5 mL | 3 days | Clinical Biochemistry | |
35 | Urine - Random | Albumin / creatinine ratio | n/a | 1 day | Clinical Biochemistry | |
14 | Plasma | Aldosterone | 5 mL | 21 days | Clinical Biochemistry | |
24 | Serum | Alk Phos Isoenzymes | 5 mL | 7 days | Clinical Biochemistry | |
24 | Serum | Allergen specific IgE | 2 mL | 7 working days | Immunology | |
24 | Serum | ALP | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
24 | Serum | Alpha 1 antitrypsin activity | 5 mL | 3 days | Clinical Biochemistry | |
24 | Serum | Alpha 1 antitrypsin phenotype | 5 mL | 14 working days | Immunology | |
24 | Serum | Alpha subunit | 2 mL | 28 days | Clinical Biochemistry | |
24 | Serum | ALT | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
10 | Whole Blood | Aluminium | 5 mL | 7 days | Clinical Biochemistry | |
24 | Serum | AMH | 2 mL | 1 week | Clinical Biochemistry | |
24 | Serum | Amikacin | <1 day | Antimicrobial Reference Laboratory | ||
34 | CSF | Amino Acids CSF | 1 mL | 14 days | Clinical Biochemistry | |
20 | Plasma | Amino Acids Plasma | 2 mL | 21 days | Clinical Biochemistry | |
35 | Urine - Random | Amino Acids Urine | 5 mL | 21 days | Clinical Biochemistry | |
14 | Plasma | Amiodarone | 5 mL | 7 days | Clinical Biochemistry | |
14 | Plasma | Ammonia | 1 mL | 2 hours | Clinical Biochemistry | |
24 | Fluid | Amylase | 5 mL | 3 days | Clinical Biochemistry | |
35 | Urine - Random | Amylase | 5 mL | 4 hours | Clinical Biochemistry | |
24 | Serum | ANCA | 2 mL | 4 working days | Immunology | |
24 | Serum | Androstenedione | 5 mL | 28 days | Clinical Biochemistry | |
24 | Serum | Anion Gap | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
16 | Whole Blood | Antenatal Blood Group and Antibody Screen | 4 mL | 1 day | Blood Transfusion | |
24 | Serum | Anti Cardiolipin Antibody | 2ml | 1 week | Immunology | |
24 | Serum | Anti PLA2 R | 2ml | 2 weeks | Immunology | |
13 | Whole Blood | Anti Thrombin | 3 full tubes | 21 days | Haematology | |
13 | Plasma | Anti-Xa | 2.7 mL | 24 hours | Haematology | |
16 | Whole Blood | ANTIBODY Investigation (red cells) | 6ml x 2 | Up to 72 hours | Blood Transfusion | |
24 | Serum | Antimicrobial assays | 5 mL | 1 day | Microbiology | |
24 | Serum | Antinuclear Antibody | 2 mL | 4 working days | Immunology | |
14 | Whole Blood | Apo E genotyping | 4 mL | 28 days | Genetics | |
24 | Serum | Apolipoprotein B | 1 mL | 1 week | Clinical Biochemistry | |
13 | Whole Blood | APTT/APTT-R | 2.7 mL | 24 hours | Haematology | |
14 | Whole blood | Arsenic | 2 mL | 2 weeks | Clinical Biochemistry | |
34 | Urine | Arsenic (urine) | 5 mL | 2 weeks | Clinical Biochemistry | |
25 | Fluid | Asialotransferrin | see notes | 3 working days | Immunology | |
24 | Clotted blood samples | Aspergillus Antigen | 700µL | Mean 1 day | Mycology Reference Laboratory | |
24 | Clotted blood samples | Aspergillus Antigen | 700µL | Mean 1 day | Mycology Reference Laboratory | |
34 | Broncheolar lavage (BAL) samples | Aspergillus Antigen | 700µL | Mean 1 day | Mycology Reference Laboratory | |
34 | Broncheolar lavage (BAL) samples | Aspergillus Antigen | 700µL | Mean 1 day | Mycology Reference Laboratory | |
24 | serum | Aspergillus IgG | 2ml | 1 week | Immunology | |
24 | Clotted blood samples | Aspergillus Precipitins | 200µL | Mean 3 days | Mycology Reference Laboratory | |
24 | Clotted blood samples | Aspergillus Precipitins | 200µL | Mean 3 days | Mycology Reference Laboratory | |
24 | Serum | AST | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
11 | Faecal sample | Astrovirus PCR (In house) |
pea sized amount | 2 days | Virology | |
24 | Serum | Autoimmune Liver Disease Antibodies | 2 mL | 4 working days | Immunology | |
34 | Nasopharayngeal aspirates (NPAs) | Avian influenza A PCR Molecular assay (NAAT) |
2 days | Virology | ||
43 | Swabs (nose and throat) | Avian Influenza A PCR Molecular assay (NAAT) |
500µL | 2 days | Virology | |
34 | Bronchoalveolar lavage (BALs) and Sputums | Avian influenza A PCR Molecular Assay | 500µL | 2 days | Virology | |
24 | Serum | Avian proteins IgG | 2ml | 1 week | Immunology | |
34 | BAL MCS | BAL MCS | 3 mL | 12 days | Microbiology | |
35 | Urine - Random | Barbiturates | 5 mL | 3 days | Clinical Biochemistry | |
24 | Serum | Benzylpenicillin (Penicillin G) | <3 days | Antimicrobial Reference Laboratory | ||
24 | Serum | Beta 2 Glycoprotein 1 | 2 mL | 7 working days | Immunology | |
24 | Serum | Beta 2 microglobulin | 2 mL | 7 working days | Immunology | |
24 | Clotted blood samples | Beta D Glucan | 200µL | Mean <1 day | Mycology Reference Laboratory | |
24 | Clotted blood samples | Beta D Glucan | 200µL | Mean <1 day | Mycology Reference Laboratory | |
24 | Serum | Bicarbonate | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
24 | Serum | Bilirubin | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
Plasma | Bilirubin - infants | 1 full paediatric lithium heparin tube | 4 hours | Clinical Biochemistry | ||
24 | Serum | Bilirubin-(Conjugated fraction) | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
9 | Blood spot | Biopterins | 6x Spots | 28 days | Clinical Biochemistry | |
14 | Plasma | Biotinidase | 1 mL | 7 days | Clinical Biochemistry | |
34 | Urine | BK virus (quantitative) PCR (In house) |
500µl | 3 days | Virology | |
14 | EDTA Blood sample | BK virus (quantitative) PCR (In house) |
450µl | 3 days | Virology | |
14 | Whole Blood | Blood Film | 24 hours | Haematology | ||
18 | Whole Blood | Blood Gases | see notes | n/a | Clinical Biochemistry | |
Bone Marrow | Bone Marrow Aspirate or Trephine | Haematology | ||||
24 | Serum | Bone profile | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
43 | Pernasal swabs | Bordetella parapertussis Molecular assay (NAAT) |
500µL | 3 days | Virology | |
43 | Pernasal swabs | Bordetella pertussis Molecular assay (NAAT) |
500µL | 3 days | Virology | |
24 | Clotted blood sample | Bordetella pertussis antibodies IgG |
170µL | 3 days | Virology | |
24 | Clotted blood sample | Borrelia burgdorferi (Lyme) antibodies IgG and IgM |
370µL | 3 days | Virology | |
28 | Urine - Random | C-peptide : creatinine ratio | 2 mL | 1 week | Clinical Biochemistry | |
14 | Plasma | C-Peptide (plasma) | 5ml | 1 week | Clinical Biochemistry | |
11 | Faeces | C.difficile toxin | 3 spoons/ pot should be at least 1/3 full | 24 hours | Microbiology | |
24 | Serum | C1 Esterase Inhibitor | 2 mL | 14 working days | Immunology | |
14 | Whole Blood | C3 Degradation Products | 3 mL | 5 working days | Immunology | |
24 | Serum | C3 Nephritic Factor | 2 mL | 7 working days | Immunology | |
24 | Serum | CA 125 | 5 mL | 1 day | Clinical Biochemistry | |
24 | Serum | CA 15-3 | 5 mL | 1 day | Clinical Biochemistry | |
24 | Serum | CA 19-9 | 5 mL | 1 day | Clinical Biochemistry | |
35 | Urine - Random | Cadmium | 5 mL | 14 days | Clinical Biochemistry | |
14 | Whole Blood | Cadmium | 4 mL | 14 days | Clinical Biochemistry | |
24 | Serum | Caeruloplasmin | 5 mL | 4 days | Clinical Biochemistry | |
24 | Serum | Calcitonin | 5 mL | 14 days | Clinical Biochemistry | |
4 | Urine - 24 hour | Calcium | n/a | 3 days | Clinical Biochemistry | |
24 | Serum | Calcium | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
27 | Serum and Urine | Calcium excretion index | 5 mL | 3 days | Clinical Biochemistry | |
11 | Faeces | Calprotectin | 5 g | 7 working days | Immunology | |
24 | Clotted blood samples | Candida Antigen | 300µL | Mean 1.6 days | Mycology Reference Laboratory | |
35 | Urine - Random | Cannabinoids | 5 mL | 3 days | Clinical Biochemistry | |
24 | Serum | Carbamazepine | 5 mL | 1 day | Clinical Biochemistry | |
18 | Whole Blood | Carboxyhaemoglobin | full tube | n/a | Clinical Biochemistry | |
24 | Serum | Cardiac Muscle Antibody | 2 mL | 21 working days | Immunology | |
35 | Urine - Random | Carnitine, | 5 mL | 14 days | Clinical Biochemistry | |
Urine - 24 hour | Catecholamines | |||||
14 | Whole Blood | CD 4 Counts | 3 mL | 1 working day | Immunology | |
24 | Serum | CDT | 5 mL | 14 days | Clinical Biochemistry | |
24 | Serum | CEA | 5 mL | 1 day | Clinical Biochemistry | |
24 | Serum | Centromere Antibody | 2 mL | 7 working days | Immunology | |
43 | Swabs (nose and throat) | Chlamydia pneumoniae Molecular assay (NAAT) Biofire Film array |
500µL | 2 days | Virology | |
38 | Aptima Urine | Chlamydia trachomatis NAAT |
1 tube | 3 days | Virology | |
1 | Aptima Swab | Chlamydia trachomatis NAAT |
1 tube | 3 days | Virology | |
24 | Clotted blood sample | Chlamydia trachomatis antibodies IgG |
150µL | 3 days | Virology | |
1 | Swab (eye) | Chlamydia trachomatis/Neisseria gonorrhoeae NAAT |
1 tube | 3 days | Virology | |
37 | See Notes | Chlamydia/ GC other swabs | n/a | 10 days | Microbiology | |
38 | Urine - Random | Chlamydia/ GC urine | n/a | 10 days | Microbiology | |
1 | See Notes | Chlamydia/ GC vaginal swabs | n/a | 10 days | Microbiology | |
24 | Serum | Chloramphenicol | <3 days | Antimicrobial Reference Laboratory | ||
24 | Serum | Chloride | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
20 | Plasma | Cholestanol | 1 mL | 21 days | Clinical Biochemistry | |
24 | Serum | Cholesterol | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
24 | Fluid | Cholesterol | 2 mL | 3 days | Clinical Biochemistry | |
14 | Whole Blood | Cholinesterase Genotype | 4 mL | 10 - 12 weeks | Clinical Biochemistry | |
14 | EDTA (whole blood) | Cholinesterase Studies | 5 mL | 3 - 4 weeks | Clinical Biochemistry | |
14 | Whole Blood | Chromium | 4 mL | 14 days | Clinical Biochemistry | |
14 | Plasma | Chromogranin A | 5 mL | 21 days | Clinical Biochemistry | |
14 | Plasma | Chromogranin B | 5 mL | 28 days | Clinical Biochemistry | |
24 | Serum | Ciprofloxacin | <3 days | Antimicrobial Reference Laboratory | ||
4 | Urine - 24 hour | Citrate | n/a | 7 days | Clinical Biochemistry | |
20 | Plasma | Citrulline | 1 mL | Clinical Biochemistry | ||
24 | Serum | CK | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
13 | Whole Blood | Clauss Fibrinogen | 2.7 mL | 24 hours | Haematology | |
13 | Whole Blood | Clotting Screen | 2.7 mL | 24 hours | Haematology | |
14 | Plasma | Clozapine Level | 2.7 mL | 10 days | Haematology | |
34 | Urine | CMV PCR (In house) |
500µl | 3 days | Virology | |
24 | Clotted blood sample | CMV IgG | 170µL | 3 days | Virology | |
24 | Clotted blood sample | CMV IgM | 170µL | 3 days | Virology | |
14 | Whole Blood | Cobalt | 4 mL | 14 days | Clinical Biochemistry | |
24 | Serum | Colistin | <3 days |
Antimicrobial Reference Laboratory | ||
24 | Serum | Complement C3 + C4 | 2 mL | 4 working days | Immunology | |
24 | Serum | Complement Function | 5 mL | 28 working days | Immunology | |
24 | Serum | Copeptin | 5 mL | 14 days | Clinical Biochemistry | |
24 | Serum | Copper | 5 mL | 7 days | Clinical Biochemistry | |
5 | Urine - 24 hour | Copper | n/a | 7 days | Clinical Biochemistry | |
43 | Swabs (nose and throat) | Coronaviurs Molecular assay (NAAT) Biofire Film array |
500µL | 2 days | Virology | |
24 | Serum | Cortisol | 5 mL | 1 day | Clinical Biochemistry | |
34 | Nasopharayngeal aspirates (NPAs) | COVID-19 Molecular assay (NAAT) |
500µL | 1 day | Virology | |
43 | Swabs (nose and throat) | COVID-19 Molecular assay (NAAT) |
500µL | 1 day | Virology | |
34 | Bronchoalveolar lavage (BALs) and Sputums | COVID-19 Molecular assay (NAAT) |
500µL | 1 day | Virology | |
20 | Plasma | Creatine Studies | 2 mL | 21 days | Clinical Biochemistry | |
35 | Urine - Random | Creatine Studies | 5 mL | 14 days | Clinical Biochemistry | |
24 | Fluid | Creatinine | 2 mL | 3 days | Clinical Biochemistry | |
34 | Dialysate | Creatinine | 2 mL | 1 day | Clinical Biochemistry | |
24 | Serum | Creatinine | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
26 | Serum and Urine | Creatinine clearance | n/a | 8 hours | Clinical Biochemistry | |
24 | Serum | Crithidia for dsDNA antibodies | 2ml | 14 working days | Immunology | |
19 | Whole Blood | Crossmatch - (Lymphocyte) for Renal Transplantation Immunology | see notes | See notes | Immunology | |
16 | Whole Blood | Crossmatch - Blood Transfusion | 4 mL | See Notes | Blood Transfusion | |
24 | Serum | CRP | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
24 | Serum | Cryoglobulin | see notes | 10 working days | Immunology | |
CSF | CSF neurodegenerative markers | 0.5mL in each tube | 10 working days | Clinical Biochemistry | ||
14 | Plasma | CTx | 2 mL | 21 days | Clinical Biochemistry | |
24 | Serum | Cyclic Citrullinated Peptide Antibodies | 2 mL | 14 working days | Immunology | |
24 | Serum | Cycloserine | <3 days | Antimicrobial Reference Laboratory | ||
14 | Whole Blood | Cyclosporin | 4 mL | 3 days | Clinical Biochemistry | |
24 | Serum | Cystatin C | 2mL | 7 days | Clinical Biochemistry | |
4 | Urine - 24 hour | Cystine 24 hour excretion | n/a | 21 days | Clinical Biochemistry | |
33 | Urine - timed | Cystine day/night | n/a | 21 days | Clinical Biochemistry | |
35 | Urine - Random | Cystine Random Urine | 5 mL | 21 days | Clinical Biochemistry | |
34 | CSF | Cytomegalovirus CMV (quantitative) PCR (In house) |
200µl | 3 days | Virology | |
14 | EDTA Blood sample | Cytomegalovirus CMV (quantitative) PCR (In house) |
450µl | 3 days | Virology | |
34 | Amniotic fluid | Cytomegalovirus CMV (quantitative) PCR (In house) |
200µl | 3 days | Virology | |
34 | Nasopharayngeal aspirates (NPAs) | Cytomegalovirus CMV(qualitative) PCR (In house) |
500µL | 3 days | Virology | |
24 | Clotted blood sample | Cytomegalovirus IgG avidity | 170µL | 3 days | Virology | |
34 | Bronchoalveolar lavage (BALs) and Sputums | Cytomegaloviurs CMV (qualitative) PCR (In house) |
500µL | 3 days | Virology | |
13 | Whole Blood | D-Dimer | 2.7 mL | 24 hours | Haematology | |
24 | Serum | Daptomycin | <3 days | Antimicrobial Reference Laboratory | ||
14 | Whole Blood | DAT | 3 mL | 24 hours | Blood Transfusion | |
24 | Serum | DHEAS | 5 mL | 10 days | Clinical Biochemistry | |
24 | Serum | Diabetes Autoantibodies (ZnT8, GAD, IA2) | 2 mL | 28 working days | Immunology | |
24 | Serum | Digoxin | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
24 | Serum | Down's Syndrome Screening | 5 mL | 7 days | Clinical Biochemistry | |
35 | Urine - Random | Drug (Overdose) Screen | 5 mL | 3 days | Clinical Biochemistry | |
35 | Urine - Random | Drugs of Abuse | 5 mL | 4 days | Clinical Biochemistry | |
24 | Serum | ds-DNA antibodies | 2 mL | 7 working days | Immunology | |
14 | EDTA Blood sample | EBV (quantitative) PCR (In house) |
450µl | 3 days | Virology | |
24 | Serum | eGFR | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
24 | Fluid | Electrolytes | 2 mL | 3 days | Clinical Biochemistry | |
24 | Serum | ELF | 5 mL | 10 days | Clinical Biochemistry | |
24 | Serum | Endomysium Antibody | 2 mL | Immunology | ||
43 | Swabs Throat swab | Enterovirus PCR (In house) |
500µL | 3 days | Virology | |
43 | Vesicle Swab | Enterovirus PCR (In house) |
500µl | Virology | ||
34 | Vesicle fluid | Enterovirus PCR (In house) |
500µl | 3 days | Virology | |
34 | CSF | Enterovirus PCR (In house) |
200µl | 3 days | Virology | |
43 | Vesicle swab | Enterovirus PCR (In house) |
500µl | 3 days | Virology | |
14 | EDTA Blood sample | Enterovirus PCR (In house) |
450µl | 3 days | Virology | |
11 | Faecal sample | Enterovirus PCR (In house) |
pea sized amount | 3 days | Virology | |
24 | Whole Blood | EPO | 5 mL | 10 days | Clinical Biochemistry | |
24 | Clotted blood sample | Epstein Barr Virus (EBV) IgG | 170µL | 3 days | Virology | |
24 | Clotted blood sample | Epstein Barr Virus (EBV) serology EBNA VCA IgG and IgM |
340µL | 3 days | Virology | |
34 | CSF | Epstein Barr Virus EBV (qualitative) PCR (In house) |
200µl | 3 days | Virology | |
24 | Serum | Ethambutol | <3 days |
Antimicrobial Reference Laboratory | ||
35 | Urine - Random | Ethanol | 2 mL | 1 day | Clinical Biochemistry | |
17 | Plasma | Ethanol | 5 mL | 4 hours | Clinical Biochemistry | |
17 | Plasma | Ethylene glycol | 5 mL | 1 day | Clinical Biochemistry | |
24 | Serum | Extractable Nuclear Antigen | 2 mL | 7 working days | Immunology | |
14 | Whole Blood | Fabry Screen | 4 mL | 2-3 weeks | Clinical Biochemistry | |
13 | Plasma | Factor II | 2 full tubes | 2 weeks | Haematology | |
13 | Whole Blood | Factor IX Assay | 2.7 mL | 10 days | Haematology | |
13 | Plasma | Factor V | 2 full tubes | 2 weeks | Haematology | |
13 | Whole Blood | Factor V Leiden | 2.7 mL | 1 month | Haematology | |
13 | Plasma | Factor VII | 2 full tubes | 2 weeks | Haematology | |
13 | Whole Blood | Factor VIII Assay | 2.7 mL | 10 days | Haematology | |
13 | Plasma | Factor VIII Inhibitor | 2 full tubes | 2 weeks, urgents will be processed as required following discussion with Haematologist | Haematology | |
13 | Plasma | Factor X | 2 full tubes | 10 days | Haematology | |
13 | Plasma | Factor XI | 2 full tubes | 10 days | Haematology | |
13 | Plasma | Factor XII | 2 full tubes | 10 days | Haematology | |
13 | Plasma | Factor XIII | 2 full tubes | 10 days | Haematology | |
11 | Faeces | Faecal Elastase | 5 g | 16 working days | Immunology | |
Faecal reducing substances | ||||||
Fat Globules | ||||||
24 | Serum | Ferritin | 5 mL | 24 hours | Clinical Biochemistry | |
14 | Plasma | FGF-23 | 2 mL | 4 weeks | Clinical Biochemistry | |
24 | Plasma AND Serum | FIB-4 | 5 mL | 24 hours | Clinical Biochemistry | |
Faecal | FIT | 2 working days | Immunology | |||
24 | Serum | Flucloxacillin | <3 days | Antimicrobial Reference Laboratory | ||
Serum | Fluconazole | < 2 days | Antimicrobial Reference Laboratory | |||
Serum | Flucytosine | < 2 days | Antimicrobial Reference Laboratory | |||
16 | Whole Blood | Foetal leak investigation | 4 mL | 1 day | Blood Transfusion | |
24 | Serum | Folate | 5 mL | 24 hours | Clinical Biochemistry | |
24 | Serum | Free androgen index | 5 mL | 7 days | Clinical Biochemistry | |
17 | Plasma (fluoride oxalate) | Free Fatty Acids | 2 mL | 7 days | Clinical Biochemistry | |
16 | Whole Blood | Free fetal DNA for fetal Rh typing | 4 mL | 15 days | Blood Transfusion | |
24 | Serum | Free Light Chains | 2 mL | 7 working days | Immunology | |
24 | Serum | Free Testosterone | 5 mL | 7 days | Clinical Biochemistry | |
24 | Serum | Fructosamine | 5 mL | 7 days | Clinical Biochemistry | |
24 | Serum | FSH | 5 mL | 1 day | Clinical Biochemistry | |
14 | Whole Blood | Full Blood Count | 4 mL | 24 hours | Haematology | |
35 | Urine - Random | Galactitol | 5 mL | 28 days | Clinical Biochemistry | |
20 | Whole Blood | Galactokinase | 1 mL | 14 days | Clinical Biochemistry | |
20 | Whole Blood | Galactosaemia screen | 1 mL | 7 days | Clinical Biochemistry | |
20 | Whole Blood | Galactose-1-phosphate | 0.5 mL | 28 days | Clinical Biochemistry | |
20 | Whole Blood | Galactose-1-phosphate uridyl transferase (quantitative) | 1 mL | 28 days | Clinical Biochemistry | |
24 | Serum | Gamma GT | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
24 | Serum | Ganciclovir | <3 days | Antimicrobial Reference Laboratory | ||
24 | Serum | Ganglioside Antibodies | 2 mL | 21 working days | Immunology | |
24 | Serum | Gastric Parietal Cell Antibody | 2 mL | 4 working days | Immunology | |
14 | Plasma | Gastrin | 5 mL | 28 days | Clinical Biochemistry | |
24 | Serum | GBM Antibody | 2 mL | 7 working days | Immunology | |
24 | Serum | Gentamicin | <1 day | Antimicrobial Reference Laboratory | ||
14 | Whole Blood | Gilbert's Syndrome DNA Test | 4 mL | 2 weeks | Clinical Biochemistry | |
14 | Plasma | Glucagon | 5 mL | 28 days | Clinical Biochemistry | |
17 | CSF | Glucose | 2 mL | 4 hours | Clinical Biochemistry | |
17 | Fluid | Glucose | 2 mL | 3 days | Clinical Biochemistry | |
24 | Serum | Glucose (inpatients only) | 5 mL | 4 hours | Clinical Biochemistry | |
17 | Plasma | Glucose (outpatients/General practice) | 2 mL | 1 day | Clinical Biochemistry | |
14 | Whole Blood | Glucose 6 Phosphate Dehydrogenase | 4 mL | 5 working days, 10 working days if sent to referral laboratory for quantitative testing | Haematology | |
17 | Plasma | Glucose tolerance test | 2 mL | 8 hours | Clinical Biochemistry | |
17 | Plasma | Glucose tolerance test in Pregnancy | 2 mL | 1 day | Clinical Biochemistry | |
16 | Whole Blood | Group and Hold | 4 mL | 24 hours | Blood Transfusion | |
24 | Serum | Growth Hormone | 5 mL | 7 days | Clinical Biochemistry | |
14 | Plasma | Gut Hormones | 10 mL | 28 days | Clinical Biochemistry | |
11 | Faeces | H.pylori | 1/3 full/10ml minimum | 3 days | Microbiology | |
14 | Whole Blood | Haematocrit | 4 mL | 24 hours | Haematology | |
14 | Whole Blood | Haemoglobin | 4 mL | 24 hours | Haematology | |
14 | Whole Blood | Haemoglobinopathy screen | 4 mL | 3 days | Haematology | |
34 | Urine - Random and Bone Marrow | Haemosiderin | 2 mL | 7 days | Haematology | |
24 | Serum | Haptoglobin | 5 mL | 7 working days | Clinical Biochemistry | |
14 | Whole Blood | HbA1c | 4 mL | 3 working days | Haematology | |
34 | CSF | hCG | 2 mL | 21 days | Clinical Biochemistry | |
24 | Serum | hCG | 5 mL | 1 day (2 hours for urgent requests) | Clinical Biochemistry | |
See Notes | hCG (Molar) | Clinical Biochemistry | ||||
24 | Serum | HDL Cholesterol | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
24 | Clotted blood sample | Helicobacter pylori antibodies IgG |
160µL | 3 days | Virology | |
24 | Clotted blood sample | Hepatitis A IgM and IgG |
410µL | 3 days | Virology | |
14 | EDTA Blood sample | Hepatitis B (quantitative) Molecular assay |
1mL | 5 days | Virology | |
24 | Clotted blood sample | Hepatitis B Surface Antibody Anti-HBs (Quantitative) | 500µL | 3 days | Virology | |
24 | Clotted blood sample | Hepatitis B Surface Antigen (HBsAG) and confirmation antibodies | 500µL | 3 days - Screen 7 days - Confirmations | Virology | |
14 | EDTA Blood sample | Hepatitis C (genotype) PCR (In house) |
200µl | 14 days | Virology | |
14 | EDTA Blood sample | Hepatitis C (quantitative) PCR (In house) |
1mL | 5 days | Virology | |
24 | Clotted blood sample | Hepatitis C antibody Total antibody screening & confirmation testing |
500µL | 3 days - Screen 7 days - Confirmations | Virology | |
24 | Clotted blood sample | Hepatitis E IgM & IgG |
270µL | 7 days | Virology | |
24 | Clotted blood sample | Hepatits B core antibody | 500µL | 3 days | Virology | |
43 | Vesicle Swab | Herpes simplex HSV 1 and 2 PCR (In house) |
500µl | Virology | ||
34 | CSF | Herpes Simplex HSV 1 and 2 PCR (In house) |
200µl | 3 days | Virology | |
43 | Swab (eye) | Herpes simplex HSV 1 and 2 PCR (In house) |
500µl | 3 days | Virology | |
24 | Clotted blood samples | Herpes Simplex HSV 1 and 2 specific serology IgG |
190µL | 4 days | Virology | |
14 | EDTA blood sample | Herpes Simplex HSV 1and 2 PCR (In house) |
450µl | 3 days | Virology | |
14 | EDTA (whole blood) | HGA - HFE Gene Analysis | 1-5 ml | Genetics (Exeter lab) | ||
14 | EDTA Blood sample | HHV6 - Blood PCR (In house) |
450µl | 3 days | Virology | |
34 | CSF | HHV6 - CSF PCR |
450µl | 3 days | Virology | |
24 | Serum | Histone antibodies | 2 mL | 21 working days | Immunology | |
24 | Clotted blood | HIT | 1 day for urgent requests otherwise 5 days. | Haematology | ||
14 | EDTA Blood sample | HIV (quantitative) Molecular assay |
1mL | 7 days | Virology | |
24 | Clotted blood sample | HIV 1 and 2 antigen/antibody Confirmation |
500µL | 7 days - Confirmations | Virology | |
24 | Clotted blood sample | HIV 1 and 2 antigen/antibody Total antibody/antigen |
350µL | 3 days - Screen 7 days confirmations | Virology | |
24 | Serum | HLA antibody screen | 2 mL | 14 working days | Immunology | |
15 | Whole Blood | HLA type (DR,DQ,DP)Class II | 8 mL | 28 working days | Immunology | |
15 | Whole Blood | HLA type(A,B,C)Class I | 8 mL | 28 working days | Immunology | |
14 | Whole Blood | HLA-A29 | 3 mL | 14 working days | Immunology | |
14 | Whole Blood | HLA-B27 | 3 mL | 14 working days | Immunology | |
14 | Whole Blood | HLA-B51(5) | 3 mL | 14 working days | Immunology | |
14 | Whole Blood | HLA-B57(B*57:01) | 3 mL | 10 working days | Immunology | |
14 | Whole Blood | HLA-DQ2+DQ8(3) | 3 mL | 14 working days | Immunology | |
14 | Whole Blood | HLA-DR15(2) DQ6(DQB1*06:02) | 3 mL | 14 working days | Immunology | |
14 | Plasma | Homocysteine (Total) | 2 mL | 7 days | Clinical Biochemistry | |
24 | Clotted blood sample | HTLV antibody Total Antibody screening |
500µL | 3 days | Virology | |
34 | Nasopharayngeal aspirates (NPAs) | Human metapneumovirus Molecular assay (NAAT) |
500µL | 2 days | Virology | |
43 | Swabs (nose and throat) | Human metapneumovirus Molecular assay (NAAT) |
500µL | 2 days | Virology | |
34 | Bronchoalveolar lavage (BALs) and Sputums | Human metapneumovirus Molecular assay (NAAT) |
500µL | 2 days | Virology | |
35 | Urine - Random | HVA | 5 mL | 7 days | Clinical Biochemistry | |
24 | Serum | IgE | 2 mL | 7 working days | Immunology | |
24 | Serum | IGF-1 | 5 mL | 5 days | Clinical Biochemistry | |
24 | Serum | IGFBP-3 | 5 mL | 14 days | Clinical Biochemistry | |
24 | Serum | IgG Subclasses | 2 mL | 7 working days | Immunology | |
14 | Whole Blood | Immunodeficiency (Immunophenotyping) | 3 mL | 2 working days | Immunology | |
n/a | Immunodeficiency Investigations | Immunology | ||||
24 | Serum | Immunoglobulins | 2 mL | 3 working days | Immunology | |
34 | Vomit | Infection screen - Virology | n/a | 2 Days | Virology | |
7 | Various | Infection screen Carbapenemase screen (rectal swab) | n/a | 3 days | Microbiology | |
Various | Infection screen MRC Screening (Burns) | n/a | 3 days | Microbiology | ||
Various | Infection screen MRSA Screen | n/a | 3 days | Microbiology | ||
Various | Infection screen MSSA Screening (Renal/ Spinal) | n/a | 3 days | Microbiology | ||
7 | Various | Infection screen Pseudomonas Screening (NICU) | n/a | 2 days | Microbiology | |
14 | Plasma | Infectious Mononucleosis | 3 mL | 72 hours | Haematology | |
43 | Swabs (nose and throat) | Influenza A Virus Molecular assay (NAAT) |
500µL | 2 days | Virology | |
34 | Nasopharayngeal aspirates (NPAs) | Influenza A Virus Molecular assay (NAAT) |
500µL | 2 days | Virology | |
34 | Bronchoalveolar lavage (BALs) and Sputums | Influenza A virus Molecular assay (NAAT) | 500µL | 2 days | Virology | |
34 | Bronchoalveolar lavage (BALs) and Sputums | Influenza B virus Molecular assay (NAAT) |
500µL | 2 days | Virology | |
34 | Nasopharayngeal aspirates (NPAs) | Influenza B Virus Molecular assay (NAAT) |
500µL | 2 days | Virology | |
43 | Swabs (nose and throat) | Influenza B Virus Molecular assay (NAAT) |
500µL | 2 days | Virology | |
13 | Whole Blood | INR | 2.7 mL | 24 hours | Haematology | |
44 | Plasma | Insulin (Paediatric) | 1 mL | 1 working day | Clinical Biochemistry | |
24 | Serum | Insulin and C-peptide | 5 mL | 14 days | Clinical Biochemistry | |
24 | Serum | Intrinsic Factor Antibodies | 5 mL | 10 days | Clinical Biochemistry | |
24 | Serum | Iohexol GFR | 2ml | 7 days | Clinical Biochemistry | |
24 | Serum | Iron | 5 mL | <4 hours | Clinical Biochemistry | |
24 | Serum | Iron and Transferrin Saturation | 5 mL | 1 day | Clinical Biochemistry | |
Serum | Isavuconazole | < 2 days | Antimicrobial Reference Laboratory | |||
14 | Whole Blood | Isoelectric focusing for determining Abnormal Haemoglobins | 14 days | Haematology | ||
17 | Whole Blood Collected in Fluoride Oxalate (Fx) Tube | Isoniazid (+ N-Acetyl-Isoniazid) | 1-2 ml | <3 days (from day of receipt) | Antimicrobial Reference Laboratory | |
n/a | Issue of Albumin Solution | n/a | Blood Transfusion | |||
n/a | Issue of Fresh Frozen Plasma | n/a | Blood Transfusion | |||
n/a | Issue of Platelets | n/a | Blood Transfusion | |||
Serum | Itraconazole | < 2 days | Antimicrobial Reference Laboratory | |||
35 | Urine - Random | Ketones | 5 mL | n/a | Clinical Biochemistry | |
17 | CSF | Lactate | 2 mL | 4 hours | Clinical Biochemistry | |
17 | Plasma | Lactate (Laboratory analysis) | 2 mL | 4 hours | Clinical Biochemistry | |
18 | Whole Blood | Lactate (Point of Care Testing) | n/a | n/a | Clinical Biochemistry | |
14 | Plasma | Lamotrigine | 5 mL | 1 - 2 weeks | Clinical Biochemistry | |
34 | CSF | LDH | 0.5 mL | 1 day | Clinical Biochemistry | |
24 | Fluid | LDH | 2 mL | 3 days | Clinical Biochemistry | |
24 | Serum | LDH | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
24 | Serum | LDL Cholesterol | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
35 | Urine - Random | Lead | 5 mL | 7 days | Clinical Biochemistry | |
14 | Whole Blood | Lead | 1 mL | 7 days | Clinical Biochemistry | |
34 | Urine | Legionella antigen | 3 mL | 1 day | Microbiology | |
14 | Bone Marrow | Leukaemial/Lymphoma Immunophenotyping | 0.5 mL | 1 working day | Immunology | |
34 | Lymph Nodes | Leukaemial/Lymphoma Immunophenotyping | see notes | 1 working day | Immunology | |
34 | Other fluids | Leukaemial/Lymphoma Immunophenotyping | see notes | 1 working day | Immunology | |
14 | Whole Blood | Leukaemial/Lymphoma Immunophenotyping | 3 mL | 1 working day | Immunology | |
20 | Whole Blood | Leukocyte Cystine | 4 mL | 28 days | Clinical Biochemistry | |
24 | Serum | Levofloxacin | <3 days | Antimicrobial Reference Laboratory | ||
24 | Serum | LFT | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
24 | Serum | LH | 5 mL | 1 day | Clinical Biochemistry | |
24 | Serum | Linezolid | <3 days | Antimicrobial Reference Laboratory | ||
24 | Serum | Lipase | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
24 | Serum | Lipid Profile | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
24 | Serum | Lipoprotein (a) | 5 mL | 21 days | Clinical Biochemistry | |
24 | Serum | Lipoprotein Electrophoresis | 5 mL | 14 days | Clinical Biochemistry | |
24 | Serum | Lithium | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
24 | Serum | Liver Kidney Microsomal | 2 mL | 4 working days | Immunology | |
24 | Serum | Liver line blot | 2ml | 2 weeks | Immunology | |
13 | Whole Blood | Lupus Anticoagulant | 3 full tubes | 10 days | Haematology | |
20 | Whole Blood | Lymphocyte Function Tests | 7 mL | 7 working days | Immunology | |
24 | Serum | Macro CK | 5 mL | 4-6 weeks | Clinical Biochemistry | |
24 | Serum | Macroprolactin | 5 mL | 14 days | Clinical Biochemistry | |
24 | Serum | Macroprolactin confirmation | 2 mL | 3 weeks | Clinical Biochemistry | |
24 | Serum | Magnesium | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
4 | Urine - 24 hour | Magnesium | n/a | 3 days | Clinical Biochemistry | |
14 | Whole Blood | Malaria Parasites | 4 mL | 24 hours, 7 working days if sent to Referral Laboratory for confirmation | Haematology | |
10 | Whole Blood | Manganese | 5 mL | 14 days | Clinical Biochemistry | |
24 | Serum | Mannose Binding Lectin | 2 mL | 14 working days | Immunology | |
14 | Whole Blood | Manual Blood Film including White Cell differential | 24 hours | Haematology | ||
24 | Serum | Mast Cell Tryptase | 2 mL | 9 working days | Immunology | |
14 | Whole Blood | MCH | 4 mL | 24 hours | Haematology | |
14 | Whole Blood | MCHC | 4 mL | 24 hours | Haematology | |
8 | Whole Blood | MCS (Blood Culture) | Adults: 8-10mL blood per blood culture bottle; Paeds: 1-3mL blood. Wherever possible, please ensure that each bottle of the blood culture set is inoculated with the correct volume of blood. Smaller volumes adversely affect the sensitivity of the assay. | 6 days | Microbiology | |
34 | CSF | MCS (Cerebrospinal fluid) | 3 mL | 4 days | Microbiology | |
Corneal Scrapes | MCS (Corneal Scrapes) | 10 days | Microbiology | |||
7 | Swab | MCS (Ear / left / right) | n/a | 4 days | Microbiology | |
7 | Swab | MCS (Eye / left / right) | n/a | 4 days | Microbiology | |
11 | Faeces | MCS (Faeces) | 1/3 full/10ml minimum | 4 days | Microbiology | |
34 | Fluid | MCS (Fluids) | 3 mL | 7 days | Microbiology | |
7 | Swab | MCS (Genital Swabs) | n/a | 4 days | Microbiology | |
7 | Mouth | MCS (Mouth Swab) | n/a | 4 days | Microbiology | |
7 | MCS (Nose swab) | n/a | 4 days | Microbiology | ||
7 | Penile | MCS (Penile swab) | n/a | 4 days | Microbiology | |
34 | Peritoneal fluid | MCS (Peritoneal Dialysis fluid) | n/a | 6 days | Microbiology | |
34 | Pus | MCS (Pus) | n/a | 8 days | Microbiology | |
7 | Swab | MCS (Skin swab) | n/a | 4 days | Microbiology | |
34 | Sputum | MCS (Sputum) | n/a | 4 days | Microbiology | |
7 | Swab | MCS (Throat swab) | n/a | 4 days | Microbiology | |
34 | Tip | MCS (Tip) | n/a | 4 days | Microbiology | |
34 | Tissue | MCS (Tissues) | n/a | 10 days | Microbiology | |
34 | Trachael aspirate | MCS (Tracheal aspirate) | n/a | 4 days | Microbiology | |
21 | Swab | MCS (Urethral swab) | n/a | 4 days | Microbiology | |
28 | Urine | MCS (Urine Catheter) | > 3 ml | 3 days | Microbiology | |
28 | Urine | MCS (Urine) | > 3 ml | 3 days | Microbiology | |
7 | Swab | MCS (Wound Swab) | n/a | 4 days | Microbiology | |
14 | Whole Blood | MCV | 4 mL | 24 hours | Haematology | |
14 | EDTA Blood sample | Measles PCR (In house) |
450µl | 3 days | Virology | |
24 | Clotted blood sample | Measles IgG | 170µL | 4 days | Virology | |
24 | Clotted blood samples | Measles IgG and IgM | 340µL | 4 days | Virology | |
43 | Swabs (nose and throat) | Measles PCR PCR (In house) |
500µL | 3 days | Virology | |
14 | Whole Blood | Mercury | 1 mL | 14 days | Clinical Biochemistry | |
35 | Urine - Random | Mercury | 1 mL | 14 days | Clinical Biochemistry | |
24 | Serum | Meropenem | <3 days | Antimicrobial Reference Laboratory | ||
43 | Swabs (nose and throat) | MERS-CoV Molecular assay (NAAT) |
500µL | 1 day | Virology | |
24 | Serum | Mesothelin | 2 ml | Please note this test is not currently available. For further information or enquires please contact the Immunology laboratory 0117 4148366 | Immunology | |
4 | Urine - 24 hour | Metadrenalines | n/a | 7 days | Clinical Biochemistry | |
14 | Whole Blood | Metadrenalines (Plasma) | 4 mL | 2 weeks | Clinical Biochemistry | |
17 | Plasma | Methanol | 5 mL | 1 day | Clinical Biochemistry | |
34 | Fluids - e.g. CSF, vitreous | Microscopy and Culture | 200µL | Microscopy mean 1 day | Mycology Reference Laboratory | |
34 | Tissue - e.g. lung biopsy, corneal scraping | Microscopy and Culture | Microscopy mean 1 day | Mycology Reference Laboratory | ||
34 | Bronchoalveolar lavage (BALs) and Sputums | Microscopy and Culture | 300µL | Microscopy mean 1 day | Mycology Reference Laboratory | |
34 | Bronchoalveolar lavage (BALs) and Sputums | Microscopy and Culture | 300µL | Microscopy mean 1 day | Mycology Reference Laboratory | |
34 | Tissue - e.g. lung biopsy, corneal scraping | Microscopy and Culture | Microscopy mean 1 day | Mycology Reference Laboratory | ||
34 | Fluids - e.g. CSF, vitreous | Microscopy and Culture | 200µL | Microscopy mean 1 day | Mycology Reference Laboratory | |
Microscopy for Crystals | Cytology | |||||
24 | Serum | Mitochondrial antibody | 2 mL | 4 working days | Immunology | |
24 | Serum | MMA | 2 mL | 20 days | Clinical Biochemistry | |
35 | Urine - Random | MMA | 5 mL | 28 days | Clinical Biochemistry | |
24 | Serum | Moxifloxacin | <3 days | Antimicrobial Reference Laboratory | ||
14 | Bone Marrow | MRD Flow Cytometry | 0.5 mL | 1 working day | Immunology | |
35 | Urine - Random | Mucopolysaccharide screen | 5 mL | 14 days | Clinical Biochemistry | |
24 | Clotted blood sample | Mumps IgG | 150µL | 3 days | Virology | |
23 | Hair | Mycology Hair | n/a | 15 days | Microbiology | |
23 | Nail clippings | Mycology Nail | n/a | 15 days | Microbiology | |
23 | Skin & nail | Mycology Scrapings (skin and nail) | n/a | 15 days | Microbiology | |
14 | Whole Blood | Mycophenolate | 4 mL | 14 days | Clinical Biochemistry | |
43 | Swabs (nose and throat) | Mycoplasma pneumoniae Molecular assay (NAAT) Biofire Film array |
500µL | 2 days | Virology | |
Myoglobin - Urine | ||||||
24 | Serum | Myositis line blot | 2ml | 2 weeks | Immunology | |
34 | Urine - Random | NAG: Creatinine ratio | 1 mL | 4 weeks | Clinical Biochemistry | |
1 | Aptima Swab | Neisseria gonorrhoeae NAAT |
1 tube | 3 days | Virology | |
38 | Aptima Urine | Neisseria gonorrhoeae NAAT |
1 tube | 3 days | Virology | |
44 | Whole Blood | Neonatal Blood Group | 1 mL | 24 hours | Blood Transfusion | |
44 | Whole Blood | Neonatal Crossmatch - Blood Transfusion | 1 mL | See Notes | Blood Transfusion | |
44 | Whole Blood | Neonatal DAT | 1 mL | 24 hours | Blood Transfusion | |
24 | Serum | Neuron Specific Enolase | 5 mL | 3 days | Clinical Biochemistry | |
24 | Serum | Neuronal Antibody (Purkinje) | 2 mL | 14 working days | Immunology | |
14 | Plasma | Neurotensin | 5 mL | 28 days | Clinical Biochemistry | |
32 | CSF | Neurotransmitters | see notes | 4 - 6 weeks | Clinical Biochemistry | |
20 | Whole Blood | Neutrophil Function Tests | 7 mL | 2 working days | Immunology | |
9 | Blood spot | Newborn Screen | 4x Spots | Clinical Biochemistry | ||
34 | Vomit | Norovirus PCR |
pea sized amount | 2 days | Virology | |
11 | Faecal sample | Norovirus PCR (In house) |
pea sized amount | 2 days | Virology | |
24 | Serum | NT-Pro-BNP | 5 mL | 1 day | Clinical Biochemistry | |
24 | Serum | Oestradiol | 5 mL | 1 day | Clinical Biochemistry | |
25 | Serum and CSF | Oligoclonal bands | 50ul CSF, 50ul Serum | 5 working days | Immunology | |
34 | CSF | Orexin | 2mL | 42 days | Clinical Biochemistry | |
35 | Urine - Random | Organic acids | 5 mL | 14 days | Clinical Biochemistry | |
35 | Urine - Random | Orotic acid | 5 mL | 14 days | Clinical Biochemistry | |
35 | Urine - Random | Osmolality | 5 mL | Hospital patients 8 hours; GP patients 24 hours | Clinical Biochemistry | |
24 | Serum | Osmolality | 5 mL | Hospital patients 8 hours; GP patients 24 hours | Clinical Biochemistry | |
11 | Faeces/ Urine | Ova Cysts & Parasites Faeces/ Urine - Concentrate | Minimum volume: 1/3 full/10ml minimum | 4 days | Microbiology | |
24 | Serum | Ovarian Antibody | 2 mL | 21 working days | Immunology | |
4 | Urine - 24 hour | Oxalate | n/a | 7 days | Clinical Biochemistry | |
14 | Plasma | Oxalate | 5 mL | 14 days | Clinical Biochemistry | |
24 | Serum | Pancreatic Islet Cell Antibody | 2 mL | 14 working days | Immunology | |
14 | Plasma | Pancreatic Polypeptide | 5 mL | 28 days | Clinical Biochemistry | |
24 | Serum | Paracetamol | 5 mL | 4 hours | Clinical Biochemistry | |
34 | Nasopharayngeal aspirates (NPAs) | Paraflu 1 Molecular assay (NAAT) |
500µL | 2 days | Virology | |
34 | Bronchoalveolar lavage (BALs) and Sputums | Paraflu 1 Molecular assay (NAAT) |
500µL | 2 days | Virology | |
34 | Nasopharayngeal aspirates (NPAs) | Paraflu 2 Molecular assay (NAAT) |
500µL | 2 days | Virology | |
34 | Bronchoalveolar lavage (BALs) and Sputums | Paraflu 2 Molecular assay (NAAT) |
500µL | 2 days | Virology | |
43 | Swabs (nose and throat) | Paraflu 2 Molecular assay (NAAT) |
500µL | 2 days | Virology | |
34 | Bronchoalveolar lavage (BALs) and Sputums | Paraflu 3 Molecular assay (NAAT) |
500µL | 2 days | Virology | |
34 | Nasopharayngeal aspirates (NPAs) | Paraflu 3 Molecular assay (NAAT) |
500µL | 2 days | Virology | |
43 | Swabs (nose and throat) | Paraflu 3 Molecular assay (NAAT) |
500µL | 2 days | Virology | |
34 | Bronchoalveolar lavage (BALs) and Sputums | Paraflu 4 Molecular assay (NAAT) |
500µL | 2 days | Virology | |
34 | Nasopharayngeal aspirates (NPAs) | Paraflu 4 Molecular assay (NAAT) |
500µL | 2 days | Virology | |
43 | Swabs (nose and throat) | Paraflu 4 Molecular assay (NAAT) |
500µL | 2 days | Virology | |
43 | Swabs (nose and throat) | Paraflu1 Molecular assay (NAAT) |
500µL | 2 days | Virology | |
24 | Serum | Paraneoplastic line blot | 2ml | 2 weeks | Immunology | |
35 | Urine - Random | Paraquat | 5 mL | 2 days | Clinical Biochemistry | |
34 | Amniotic fluid | Parvovirus PCR (In house) |
200µl | 3 days | Virology | |
14 | EDTA Blood sample | Parvovirus PCR (In house) |
450µl | 3 days | Virology | |
24 | Clotted blood samples | Parvovirus IgG and IgM | 150µL | 4 days | Virology | |
22 | Swab | Pernasal swab (Bordetella/Whooping cough) | n/a | 8 days | Microbiology | |
24 | Serum | Phenobarbitone | 5 mL | 1 day | Clinical Biochemistry | |
9 | Blood spot | Phenylalanine | 2x Spots | 5 days | Clinical Biochemistry | |
24 | Serum | Phenytoin | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
4 | Urine - 24 hour | Phosphate | n/a | 3 days | Clinical Biochemistry | |
24 | Serum | Phosphate | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
20 | Plasma | Phytanic acid | 2 mL | 21 days | Clinical Biochemistry | |
24 | Serum | PIIINP | 2 mL | 4-6 weeks | Clinical Biochemistry | |
24 | Serum | Piperacillin | <3 days | Antimicrobial Reference Laboratory | ||
13 | Plasma | PIVKA II | 10 days | Haematology | ||
14 | Whole Blood | Plasma Viscosity | 4 mL | 3 days | Haematology | |
14 | Whole Blood | Platelet count (EDTA & Citrate) | 4 mL | 24 hours | Haematology | |
34 | Urine | Pneumococcal antigen | 3 mL | 1 day | Microbiology | |
14 | See Notes | PNH Immunophenotyping | 3 mL | 4 working days | Immunology | |
14 | Whole Blood | Porphyrin Enzyme/DNA analysis | 4 mL | 28 days | Clinical Biochemistry | |
14 | Whole Blood | Porphyrins | 5-10 mL | 15 days | Clinical Biochemistry | |
11 | Faeces | Porphyrins | 5 g | 15 days | Clinical Biochemistry | |
34 | Urine - Random | Porphyrins | 10 mL | 15 days | Clinical Biochemistry | |
Serum | Posaconazole | < 2 days | Antimicrobial Reference Laboratory | |||
5 | Urine | Potassium | n/a | 1 day | Clinical Biochemistry | |
24 | Serum | Potassium | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
24 | Serum | Prednisolone | 5 mL | 21 days | Clinical Biochemistry | |
24 | Serum | Progesterone | 5 mL | 1 day | Clinical Biochemistry | |
24 | Serum | Prolactin | 5 mL | 1 day | Clinical Biochemistry | |
24 | Fluid | Protein | 5 mL | 3 days | Clinical Biochemistry | |
34 | CSF | Protein | 2 mL | 4 hours | Clinical Biochemistry | |
35 | Urine - Random | Protein | 5 mL | 1 day | Clinical Biochemistry | |
34 | Dialysate | Protein | 5 mL | 8 hours | Clinical Biochemistry | |
24 | Serum | Protein | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
13 | Whole Blood | Protein C | 3 full tubes | 21 days | Haematology | |
13 | Whole Blood | Protein S | 3 full tubes | 21 days | Haematology | |
13 | Whole Blood | Prothrombin Gene Mutation | 3 full tubes | 1 month | Haematology | |
24 | Serum | PSA | 5 mL | 1 day | Clinical Biochemistry | |
14 | Plasma | PTH | 5 mL | 1 day | Clinical Biochemistry | |
32 | PTH-related peptide | Clinical Biochemistry | ||||
35 | Urine - Random | Purine / Pyrimidine Screen | 5 mL | 21 days | Clinical Biochemistry | |
14 | Plasma | Pyruvate Kinase | 21 days | Haematology | ||
32 | See Notes | Quantiferon | 7 working days | Immunology | ||
24 | Serum | RAST | 2 mL | Immunology | ||
14 | Whole Blood | Red Blood Count | 4 mL | 24 hours | Haematology | |
Red cell Transketolase | ||||||
14 | Plasma | Renin | 5 mL | 28 days | Clinical Biochemistry | |
34 | Nasopharayngeal aspirates (NPAs) | Respiratory syncytial virus Molecular assay (NAAT) |
500µL | 2 days | Virology | |
43 | Swabs (nose and throat) | Respiratory Syncytial Virus Molecular assay (NAAT) |
500µL | 2 days | Virology | |
34 | Bronchoalveolar lavage (BALs) and Sputums | Respiratory Syncytial Virus Molecular assay (NAAT) |
500µL | 2 days | Virology | |
14 | Whole Blood | Reticulocytes | 4 mL | 24 hours | Haematology | |
34 | Urine - Random | Retinol Binding Protein | 20 mL | 14 days | Clinical Biochemistry | |
24 | Serum | Rheumatoid Factor | 2 mL | 3 working days | Immunology | |
43 | Swabs (nose and throat) | Rhinovirus Molecular assay (NAAT) |
500µL | 2 days | Virology | |
34 | Bronchoalveolar lavage (BALs) and Sputums | Rhinovirus Molecular assay (NAAT) |
500µL | 2 days | Virology | |
34 | Nasopharayngeal aspirates (NPAs) | Rhinoviurs Molecular assay (NAAT) |
500µL | 2 days | Virology | |
24 | Serum | Rifabutin | <3 days | Antimicrobial Reference Laboratory | ||
24 | Serum | Rifampicin | <3 days | Antimicrobial Reference Laboratory | ||
13 | Whole Blood | Ristocetin Co Factor. | 2.7 mL | 21 days | Haematology | |
14 | Whole blood | Rituximab | 3ml | 2 working days | Immunology | |
11 | Faecal sample | Rotavirus PCR (In house) |
pea sized amount | 2 days | Virology | |
24 | Clotted blood samples | Rubella IgG and IgM | 150µL | 4 days | Virology | |
24 | Serum | Salicylate | 5 mL | 4 hours | Clinical Biochemistry | |
11 | Faecal sample | Sapovirus PCR (In house) |
pea sized amount | 2 days | Virology | |
24 | Serum | Selenium | 5 mL | 7 days | Clinical Biochemistry | |
5 | Urine - 24 hour | Selenium | n/a | 14 days | Clinical Biochemistry | |
24 | Serum | Serum Electrophoresis | 2 mL | 5 working days | Immunology | |
24 | Serum | SHBG | 5 mL | 7 days | Clinical Biochemistry | |
24 | Serum | Short Synacthen Test | 5 mL | 1 day | Clinical Biochemistry | |
35 | Urine - Random | Sialic acid | 5 mL | 14 days | Clinical Biochemistry | |
14 | Whole Blood | Sickle Cell Screen | 4 mL | 24 hours (confirmatory testing); 1 hour (urgent and request phoned through to lab) | Haematology | |
14 | Whole Blood | Sirolimus | 4 mL | 3 days | Clinical Biochemistry | |
24 | Serum | Skeletal Muscle Antibody | 2 mL | 21 working days | Immunology | |
24 | Serum | Skin Antibody (Pemphigus/Pemphigoid) | 2 mL | 14 working days | Immunology | |
24 | Serum | Smooth Muscle Antibody | 2 mL | 4 working days | Immunology | |
24 | Serum | Sodium | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
35 | Urine - Random | Sodium | 5 mL | 1 day | Clinical Biochemistry | |
14 | Plasma | Somatostatin | 5 mL | 28 days | Clinical Biochemistry | |
5 | Urine - 24 hour | Steroid Profile (urine) | n/a | 14 days | Clinical Biochemistry | |
34 | Stone | Stones - Renal Calculi | n/a | 14 days | Clinical Biochemistry | |
24 | Clotted blood sample | Streptococcus serology (antistreptolysin O) ASO |
150µL | 6 days | Virology | |
24 | Serum | Streptomycin | <3 days | Antimicrobial Reference Laboratory | ||
24 | Serum | Sulphamethoxazole in Co-trimoxazole | <3 days | Antimicrobial Reference Laboratory | ||
24 | Serum | Sulphonylurea | 5 mL | 28 days | Clinical Biochemistry | |
24 | Clotted blood samples | Syphilis RPR |
500µL | 7 days - Confirmations | Virology | |
24 | Clotted blood samples | Syphilis PCR Confirmation testing - IgG and IgM |
500µL | 7 days - Confirmations | Virology | |
24 | Clotted blood sample | Syphilis serology Total Antibody - Screening |
500µL | 3 days - Screen | Virology | |
24 | Serum | Systemic Sclerosis line blot | 2ml | 2 weeks | Immunology | |
14 | Whole Blood | T Cell Subsets (see CD4 Counts) | 3 mL | 1 working day | Immunology | |
14 | Whole Blood | Tacrolimus | 4 mL | 3 days | Clinical Biochemistry | |
39 | Whole Blood | TB (Mycobacterium Blood) | 3-5 mL | 70 days | Microbiology | |
6 | Urine | TB (Mycobacterium Urine) | 250 mL | 70 days | Microbiology | |
34 | Sputum/ Pus/ Tissue, NOT Swabs | TB (Mycobacterium) samples (other than Blood/ Urine) | n/a | 70 days | Microbiology | |
24 | Serum | Teicoplanin | <2 days | Antimicrobial Reference Laboratory | ||
24 | Serum | Testis Antibody | 2 mL | 21 working days | Immunology | |
24 | Serum | Testosterone | 5 mL | 1 day | Clinical Biochemistry | |
24 | Serum | Testosterone confirmation | 1 mL | 14 days | Clinical Biochemistry | |
24 | Serum | Tetanus antibodies | 2 mL | 28 working days | Immunology | |
24 | Serum | TFT confirmation | 1 mL | 3 weeks | Clinical Biochemistry | |
24 | Serum | Theophylline | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
14 | Whole Blood | Thiamine | 4 mL | 28 days | Clinical Biochemistry | |
14 | Whole Blood | Thiopurine Metabolites | 4 mL | 21 days | Clinical Biochemistry | |
14 | Whole Blood | Thiopurine methyl transferase | 4 mL | 14 days | Clinical Biochemistry | |
13 | Whole Blood | Thrombophilia Screen | 3 full tubes | 21 days | Haematology | |
24 | Serum | Thyroglobulin | 5 mL | 7 days | Clinical Biochemistry | |
24 | Serum | Thyroid Function Tests | 5 mL | 1 day | Clinical Biochemistry | |
24 | Serum | Thyroid Peroxidase Antibody | 2 mL | 7 days | Clinical Biochemistry | |
24 | Serum | Tissue Transglutaminase Antibody | 2 mL | 7 working days | Immunology | |
24 | Serum | Tobramycin | <1 day | Antimicrobial Reference Laboratory | ||
24 | Serum | Total Bile Acids | 5 mL | 1 day | Clinical Biochemistry | |
24 | Serum | Total Protein | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
24 | Clotted blood samples | Toxoplasma Total antibody & IgM |
500µL | 5 days | Virology | |
24 | Serum | Transferrin Glycoforms | 5 mL | 14 days | Clinical Biochemistry | |
16 | Whole Blood | Transfusion Reaction | 6ml | 24 hours | Blood Transfusion | |
1 | Aptima Swab | Trichomonas vaginalis NAAT |
1 tube | 3 days | Virology | |
24 | Serum | Triglycerides | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
24 | Serum | Trimethoprim in Co-trimoxazole | <3 days | Antimicrobial Reference Laboratory | ||
4 | Urine - 24 hour | Trimethylamine | n/a | 8 weeks | Clinical Biochemistry | |
24 | Serum | Troponin I | 5 mL | 4 hours | Clinical Biochemistry | |
9 | Blood spot | TSH | 2x Spots | 7 days | Clinical Biochemistry | |
24 | Serum | TSH Receptor Antibodies | 2ml | 8 working days | Immunology | |
24 | Serum | U/E (Urea and Electrolytes) | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
24 | Serum | Urate | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
3 | Urine - 24 hour | Urate | n/a | 1 day | Clinical Biochemistry | |
24 | Serum | Urea | 5 mL | Hospital patients 4 hours; GP patients 24 hours | Clinical Biochemistry | |
5 | Urine | Urine Electrolytes | n/a | 1 day | Clinical Biochemistry | |
35 | Urine - Random | Urine Electrophoresis | 1 mL | 5 working days | Immunology | |
28 | Urine | Urine for MCS | 11 mL | 3 days | Microbiology | |
5 | Urine - 24 hour | Urine Free Cortisol | n/a | 2-3 weeks | Clinical Biochemistry | |
Urine reducing substances | ||||||
5 | Urine | Urine Urea | n/a | 1 day | Clinical Biochemistry | |
5 | Urine - 24 hour | Urine volume | n/a | 2 days | Clinical Biochemistry | |
24 | Serum | Valproate | 5 mL | 7 days | Clinical Biochemistry | |
24 | Serum | Vancomycin | <1 day | Antimicrobial Reference Laboratory | ||
14 | EDTA Blood sample | Varicella zoster PCR (In house) |
450µl | 3 days | Virology | |
34 | CSF | Varicella Zoster PCR (In house) |
200µl | 3 days | Virology | |
34 | Lesion/vesicle fluid | Varicella zoster PCR (In house) |
500µl | 3 days | Virology | |
43 | Vesicle Swab | Varicella zoster PCR (In house) |
500µl | 3 days | Virology | |
24 | Clotted blood samples | Varicella zoster IgG | 170µL | 3 days | Virology | |
24 | Serum | VEGF | 2 mL | 21 days | Clinical Biochemistry | |
20 | Plasma | Very long chain fatty acids | 2 mL | 21 days | Clinical Biochemistry | |
14 | Plasma | VIP | 5 mL | 28 days | Clinical Biochemistry | |
Whole Blood | Viral Haemorrhagic Fever | 7 mL | 1 day | Virology | ||
0 | See link | Virology/ Serology (PHE/ REF) | n/a | 10 days | Virology | |
24 | Serum | Vitamin A | 2 mL | 14 days | Clinical Biochemistry | |
14 | Whole Blood | Vitamin B1 | 4 mL | 2 weeks | Clinical Biochemistry | |
24 | Serum | Vitamin B12 | 5 mL | 3 days | Clinical Biochemistry | |
14 | Whole blood | Vitamin B6 | 4 mL | 3 weeks | Clinical Biochemistry | |
20 | Plasma | Vitamin C | 2 mL | 4 weeks | Clinical Biochemistry | |
24 | Serum | Vitamin D | 5 mL | 7 days | Clinical Biochemistry | |
24 | Serum | Vitamin E | 2 mL | 14 days | Clinical Biochemistry | |
35 | Urine - Random | VMA | 5 mL | 7 days | Clinical Biochemistry | |
13 | Whole Blood | Von Willebrand's Disease | 2.7 mL | 3 weeks | Haematology | |
Serum | Voriconazole | < 2 days | Antimicrobial Reference Laboratory | |||
13 | Plasma | Warfarin levels | 10 days | Haematology | ||
27 | Serum and Urine | Water Deprivation Test | see notes | 1 day | Clinical Biochemistry | |
14 | Whole Blood | White Blood Count | 4 mL | 24 hours | Haematology | |
14 | Whole Blood | White Cell Enzymes | 5 mL | 3-4 weeks | Clinical Biochemistry | |
34 | CSF | Xanthochromia | 1 mL | 4 hours | Clinical Biochemistry | |
10 | Plasma | Zinc | 5 mL | 7 days | Clinical Biochemistry | |
Zinc Protoporphyrin |